IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q3 2018 Holdings

Filed 2018-11-14 | 9 holdings | $341.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Avrobio IncCOM05455M100$141.9K2,736,02741.6%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$66.5K1,716,30319.5%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$57.0K2,579,49016.7%
Transenterix IncCOM NEW89366M201$38.5K6,631,83211.3%
Sutro Biopharma IncCOM869367102$27.4K1,824,5428.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$5.0K722,9361.5%
Arsanis IncCOM042873109$3.0K1,868,9610.9%
Catabasis Pharmaceuticals inCOM14875P107$2.3K2,857,6670.7%
Reshape Life Sciences IncCOM29365M505$6150,0640.0%